AMYLYX
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 15 Dec 2025)
What this means for you
Registered since 10 Sept 2019. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 10 Sept 2029: the §8 & §9 renewal).
Record
- Serial number
- 88319636
- Registration number
- 5856852
- Mark type
- Word mark
- Filed
- 28 Feb 2019
- Published for opposition
- 25 Jun 2019
- Registered
- 10 Sept 2019
- Next maintenance filing
- §8 & §9 renewal, due by 10 Sept 2029 (grace period to 10 Mar 2030)
- Attorney of record
- Cynthia Johnson Walden
Goods and services
- Class 042 — Scientific and technological services: Pharmaceutical research and development; pharmaceutical drug development services; testing of pharmaceuticals
Owner
- Amylyx Pharmaceuticals, Inc., Cambridge, MA, US
- Amylyx Pharmaceuticals, Inc., Cambridge, MA, US
- Amylyx Pharmaceuticals, Inc., Cambridge, MA, US
Board proceedings on this mark
The owner also pleads this mark in 1 other Board proceeding.
Prosecution history
- 23 Feb 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 23 Feb 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 23 Feb 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 23 Feb 2026 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 23 Feb 2026 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 15 Dec 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 15 Dec 2025 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 15 Dec 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 10 Sept 2025 — TEAS SECTION 8 & 15 RECEIVED
- 10 Sept 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 10 Sept 2019 — REGISTERED-PRINCIPAL REGISTER
- 25 Jul 2019 — ASSIGNED TO EXAMINER
- 25 Jun 2019 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 25 Jun 2019 — PUBLISHED FOR OPPOSITION
- 05 Jun 2019 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED